Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer
Authors
Keywords
CAF, Cytokine, Angiogenesis, Gastric cancer, Overall survival
Journal
Gastric Cancer
Volume 20, Issue 1, Pages 164-174
Publisher
Springer Nature
Online
2015-12-17
DOI
10.1007/s10120-015-0583-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
- (2015) J. M. Taube et al. CLINICAL CANCER RESEARCH
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
- (2015) Jaromir Pastorek et al. SEMINARS IN CANCER BIOLOGY
- Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer
- (2015) Jinjia Chang et al. Oncotarget
- Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis
- (2014) L. Barrera et al. ANNALS OF ONCOLOGY
- A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
- (2014) Y-K Kang et al. BRITISH JOURNAL OF CANCER
- Interleukin-8 and Interleukin-17 for Cancer
- (2014) Paul Zarogoulidis et al. CANCER INVESTIGATION
- Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
- (2014) M. F. Sanmamed et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies
- (2014) R. Salgia et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Circulating cytokines and gastric cancer risk
- (2013) Meira Epplein et al. CANCER CAUSES & CONTROL
- Autocrine IL-8 and VEGF mediate epithelial–mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells
- (2013) Sejal Desai et al. CELLULAR SIGNALLING
- Prognostic Significance of Serum Levels of Vascular Endothelial Growth Factor and Insulin-Like Growth Factor-1 in Advanced Gastric Cancer Patients Treated with FOLFOX Chemotherapy
- (2013) Sung Yong Oh et al. CHEMOTHERAPY
- Clinicopathological Implications of the Expression of Hypoxia-related Proteins in Gastric Cancer
- (2013) Ji-Han Jung et al. International Journal of Medical Sciences
- Role of IL-8 induced angiogenesis in uveal melanoma
- (2013) Laura Lattanzio et al. INVESTIGATIONAL NEW DRUGS
- Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma
- (2013) Rekha Gyanchandani et al. ORAL ONCOLOGY
- Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis
- (2012) A. M. Dulak et al. CANCER RESEARCH
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
- (2012) Hai T Tran et al. LANCET ONCOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
- (2011) Jun-Eul Hwang et al. BMC CANCER
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Signet Ring Cell Carcinoma of the Stomach Is Significantly Associated with Poor Prognosis and Diffuse Gastric Cancer (Lauren’s): Single-Center Experience of 160 Cases
- (2011) Holger G. Hass et al. ONKOLOGIE
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer
- (2010) L. A. Byers et al. MOLECULAR CANCER THERAPEUTICS
- Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon- : association of pretreatment serum levels with survival
- (2009) A. J. Montero et al. ANNALS OF ONCOLOGY
- Positive Correlation of Osteopontin, Cyclooxygenase-2 and Vascular Endothelial Growth Factor in Gastric Cancer
- (2008) Hongwei Tang et al. CANCER INVESTIGATION
- Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
- (2008) J. Chiche et al. CANCER RESEARCH
- Hypoxia-inducible factor (HIF)-1 directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)
- (2008) Z.-B. Han et al. CARCINOGENESIS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started